CAMBRIDGE, Mass., Sept. 16, 2013 /PRNewswire/ -- Aptel Research, a specialty marketing research and consulting company that provides actionable strategic insights to the pharmaceutical and biotech industries, today launched Patient Voices Syndicated Report Series. Patient Voices Syndicated Report Series provides rich insights into the emotional and rational factors that impact the patient journey through specific chronic diseases in specialty markets. The first report covers multiple sclerosis in the United States. Future reports will cover other chronic diseases in the U.S. and in international markets. Each report captures the various aspects of the patient journey from symptoms to diagnosis to treatment, and identifies issues and gaps along the way. The reports employ a mix of qualitative interviews, quantitative surveys, and an analysis of patient social media to create a nuanced understanding of patients' experiences, as well as brand attitudes and unmet needs.
"Patients with relapsing forms of MS are fortunate to have many treatment options now, including oral treatments," said Aptel Research CEO Michele Derai. "The MS landscape is rapidly changing and additional multiple sclerosis agents are in various stages of development in the U.S. and abroad. The Patient Voices Syndicated Report Series will serve the product life-cycle needs of our clients by allowing them to differentiate their products to best match patients' lives and mindsets at any point in their journey. The insights provided by the Patient Voices Syndicated Report Series will enable our clients to uncover new marketing opportunities."
With decades of experience, in-depth business and scientific expertise and a global network, Aptel Research offers customized strategic market research from market assessment to branding strategy with key target audiences, including key opinion leaders.
For more information visit Aptel Research.
Media contact: Jane A. Kramer 781-799-9524
SOURCE Aptel Research